Head-To-Head Survey: Globus Medical (NYSE:GMED) vs. Inspira Technologies Oxy B.H.N. (NASDAQ:IINN)

Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Globus Medical (NYSE:GMED) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Inspira Technologies Oxy B.H.N. and Globus Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies Oxy B.H.N.	0	0	0	0	0.00
Globus Medical	1	2	9	0	2.67

Globus Medical has a consensus target price of $94.55, indicating a potential upside of 15.61%. Given Globus Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Globus Medical is more favorable than Inspira Technologies Oxy B.H.N..

Risk and Volatility

Inspira Technologies Oxy B.H.N. has a beta of 2.07, suggesting that its share price is 107% more volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500.

Earnings & Valuation

This table compares Inspira Technologies Oxy B.H.N. and Globus Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies Oxy B.H.N.	N/A	N/A	-$11.29 million	N/A	N/A
Globus Medical	$2.48 billion	4.49	$122.87 million	$0.67	122.06

Globus Medical has higher revenue and earnings than Inspira Technologies Oxy B.H.N..

Profitability

This table compares Inspira Technologies Oxy B.H.N. and Globus Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inspira Technologies Oxy B.H.N.	N/A	N/A	N/A
Globus Medical	3.69%	9.98%	7.92%

Institutional and Insider Ownership

12.7% of Inspira Technologies Oxy B.H.N. shares are held by institutional investors. Comparatively, 95.2% of Globus Medical shares are held by institutional investors. 29.4% of Inspira Technologies Oxy B.H.N. shares are held by insiders. Comparatively, 18.5% of Globus Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Globus Medical beats Inspira Technologies Oxy B.H.N. on 9 of the 11 factors compared between the two stocks.

About Inspira Technologies Oxy B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.